Clinical trial
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell…
NCT00041015 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00041015 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment For Chemotherapy-Naive Patients With Extensive Disease - Small Cell Lung |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, etoposide, topotecan hydrochloride |
| Enrollment | 4 |
| Start date | Sep 1, 2001 |
| Primary completion | Nov 1, 2002 |
| Completion | Nov 1, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: